a public good project by the
Synthesis
Company
of California

© 2026

Jamie Saunders | doi.page

0 works0 citations0 h-index

Jamie Saunders

National Institutes of Health(US)National Institute of Allergy and Infectious Diseases(US)

Publications by Year

Research Areas

SARS-CoV-2 and COVID-19 Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, HIV Research and Treatment, Mosquito-borne diseases and control

Most-Cited Works

→ Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine(2013)772 cited
→ Protection against malaria at 1 year and immune correlates following PfSPZ vaccination(2016)374 cited
→ A proof of concept for structure-based vaccine design targeting RSV in humans(2019)327 cited
→ Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials(2017)300 cited
→ Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection(2017)251 cited
→ Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults(2015)251 cited

→ Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults(2018)

251 cited

→ Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial(2014)248 cited

→ Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial(2022)157 cited

→ Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial(2014)131 cited